Indivior loses battle over Suboxone generic
22-11-2018
Indivior settles addiction drug dispute with Par
16-05-2018
Indivior pledges to appeal generic Suboxone decision
26-03-2018
18-06-2018
Kerrick / iStockphoto.com
Addiction treatment drug producer Indivior has obtained a temporary restraining order against Indian generic maker Dr Reddy’s, blocking the company from launching a generic version of Suboxone (buprenorphine and naloxone) Film.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Indivior, generics, Suboxone, Dr Reddy’s, patent infringement, opioid addiction, ANDA, FDA